Personalised medicine has been an important focus for ERS and was the subject of the ERS Presidential Summit, 2015. Great advances in technology and research have allowed greater scope for individualising treatment and it is essential that all stakeholders work together to effectively implement the changes this will bring for healthcare. The ERS Congress is a key date in the calendar for respiratory professionals to join together and share knowledge on this subject.
Chair of the ERS Science Council Professor Stephen Holgate said: "Personalised medicine has the potential to benefit a great number of respiratory patients. Better phenotyping, helped by and combined with better data from ehealth technologies using electronic patient records, analytical platforms and real-time monitoring, could lead to marked improvements in people's lives. Join the conversation on shaping and implementing personalisation with a global community of respiratory stakeholders at Congress."
Better understanding of phenotypes will aid better decisions for treatment options; this topic will be featuring in a number of sessions including Russia Day, which will include discussions on the personalisation of COPD, and updates from EU-funded projects AirPROM and U-BIOPRED, which are focusing on improving treatments for asthma and COPD.
Sessions and symposia throughout Congress are complemented by practical sessions dealing with the implementation of personalised medicine and educational sessions aimed at basic scientists as well as clinicians.
Below we highlight just some of the Congress sessions on offer for this topic. Browse the full programme online.
*Registration for these courses is additional to the Congress registration fee. Junior members can register for sessions at a reduced rate.